Healthcare - Biotechnology - NASDAQ - US
$ 0.2946
-2.13 %
$ 11.1 M
Market Cap
-0.27
P/E
BALANCE SHEET
28.5 M
ASSETS
15.1 M
LIABILITIES
13.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
HCW Biologics Inc.
| Current Assets | 6.4 M |
| Cash & Short-Term Investments | 3.6 M |
| Receivables | 1.54 M |
| Other Current Assets | 1.27 M |
| Non-Current Assets | 22.1 M |
| Long-Term Investments | 1.6 M |
| PP&E | 20.5 M |
| Other Non-Current Assets | 56.5 K |
| Current Liabilities | 8.75 M |
| Accounts Payable | 6.17 M |
| Short-Term Debt | 28.5 K |
| Other Current Liabilities | 2.55 M |
| Non-Current Liabilities | 6.3 M |
| Long-Term Debt | 6.3 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 3.6 | 22.3 | 11.7 | 8.5 | 7.4 |
| Short Term Investments | 0 | 9.7 | 25.0 | 0 | 0 |
| Receivables | 1.5 | 0.4 | 0.1 | 2.5 | 0 |
| Inventory | 0 | 1.4 | 2.2 | 0.5 | 0 |
| Other Current Assets | 1.3 | 1.6 | 3.6 | 1.2 | 0.7 |
| Total Current Assets | 6.4 | 34.1 | 40.5 | 12.1 | 8.0 |
| PP&E | 20.5 | 10.8 | 1.1 | 1.6 | 2.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 1.6 | 1.6 | 11.5 | 1.6 | 0 |
| Other Long Term Assets | 56.5 K | 0.3 | 0.4 | 34.2 K | 34.2 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 28.5 | 46.8 | 53.5 | 15.4 | 10.1 |
| LIABILITIES | |||||
| Accounts Payable | 6.2 | 1.2 | 0.2 | 0.2 | 0.4 |
| Short Term Debt | 28.5 K | 0 | 0 | 0.6 | 0 |
| Other Current Liabilities | 2.6 | 1.7 | 2.1 | 0.3 | 0.7 |
| Total Current Liabilities | 8.7 | 3.0 | 2.3 | 1.0 | 1.1 |
| Long Term Debt | 6.3 | 6.4 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 14.3 K | 0 | 0 | 0 |
| Total Liabilities | 15.1 | 9.4 | 2.3 | 1.0 | 1.1 |
| EQUITY | |||||
| Common Stock | 3.6 K | 3.59 K | 3.58 K | 480 | 472 |
| Retained Earnings | (70.5) | (45.5) | (30.6) | (16.7) | (9.7) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (53.5) | 1.12 K | 1.1 K |
| Total Equity | 13.5 | 37.4 | 51.2 | 14.4 | 9.0 |
| Total Liabilities and Equity | 28.5 | 46.8 | 53.5 | 15.4 | 10.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 35.9 | 35.8 | 35.8 | 36.7 | 36.7 |